Provided by Tiger Fintech (Singapore) Pte. Ltd.

Atea Pharmaceuticals, Inc.

3.58
+0.10503.03%
Volume:204.74K
Turnover:731.37K
Market Cap:305.95M
PE:-2.17
High:3.62
Open:3.50
Low:3.50
Close:3.47
Loading ...

Atea Pharmaceuticals: Bradley L. Radoff to Nominate Three Director Candidates to Stand for Election to Co's Board

THOMSON REUTERS
·
22 Mar

Atea Pharmaceuticals Inc - Receives Notice of Director Nominations From Bradley L. Radoff

THOMSON REUTERS
·
22 Mar

Press Release: Atea Pharmaceuticals Issues Statement Regarding Director Nominations

Dow Jones
·
22 Mar

Atea Pharmaceuticals announces presentation of bemnifosbuvir preclinical data

TIPRANKS
·
19 Mar

Oramed Pharmaceuticals And 2 Other Penny Stocks With Promising Potential

Simply Wall St.
·
14 Mar

Atea Pharmaceuticals Faces Challenges Amid Workforce Reductions and Cost-Cutting Efforts

TIPRANKS
·
08 Mar

Atea Pharmaceuticals’ Promising Earnings Call Highlights

TIPRANKS
·
08 Mar

Q4 2024 Atea Pharmaceuticals Inc Earnings Call

Thomson Reuters StreetEvents
·
08 Mar

Atea Pharmaceuticals Inc (AVIR) Q4 2024 Earnings Call Highlights: Strategic Moves and Promising ...

GuruFocus.com
·
07 Mar

Atea Pharmaceuticals Cuts Workforce by 25%

Dow Jones
·
07 Mar

Atea Pharmaceuticals Inc reports results for the quarter ended December 31 - Earnings Summary

Reuters
·
07 Mar

Atea Pharmaceuticals reports Q4 EPS (40c), consensus (29c)

TIPRANKS
·
07 Mar

Atea Pharmaceuticals Q4 EPS $(0.40) Misses $(0.37) Estimate

Benzinga
·
07 Mar

BRIEF-Atea Pharmaceuticals Q4 Basic EPS USD -0.4

Reuters
·
07 Mar

Atea Pharmaceuticals Inc - Reduces Workforce by Approximately 25% in Q1 2025

THOMSON REUTERS
·
07 Mar

Atea Pharmaceuticals Inc - Expects $15 Million Cost Savings Through 2027 From Workforce Reduction

THOMSON REUTERS
·
07 Mar

Atea Pharmaceuticals Inc expected to post a loss of 37 cents a share - Earnings Preview

Reuters
·
05 Mar

Radoff Bradley Louis - Purchased Atea Pharmaceuticals' Shares Based Belief That the Shares, When Purchased, Were Undervalued

THOMSON REUTERS
·
04 Mar

Radoff Bradley Louis Reports 3.3% Stake in Atea Pharmaceuticals as of Feb 27 - SEC Filing

THOMSON REUTERS
·
04 Mar

Radoff Bradley Louis - Intend to Nominate a Competing Slate of Candidates for Election to Atea Pharmaceuticals' Board at Upcoming Annual Meeting

THOMSON REUTERS
·
04 Mar